M&A Deal Summary

3SBio Acquires Zhejiang Wansheng Pharmaceutical

On July 24, 2015, 3SBio acquired life science company Zhejiang Wansheng Pharmaceutical for 528M CNY

Acquisition Highlights
  • This is 3SBio’s 2nd transaction in the Life Science sector.
  • This is 3SBio’s largest (disclosed) transaction.
  • This is 3SBio’s 1st transaction in China.

M&A Deal Summary
Date 2015-07-24
Target Zhejiang Wansheng Pharmaceutical
Sector Life Science
Buyer(s) 3SBio
Deal Type Add-on Acquisition
Deal Value 528M CNY

Target

Zhejiang Wansheng Pharmaceutical

Zhejiang, China
Zhejiang Wansheng Pharmaceutical Co., Ltd. is a pharmaceutical company.

Search 200,066 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

3SBio

Shenyang, China
Category Company
Founded 1993
Sector Life Science
Employees5,411
Revenue 7.8B CNY (2023)
DESCRIPTION

3SBio is a biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products. 3SBio was incorporated in 1993 and is based in Shenyang, China.

DEAL STATS #
Overall 2 of 2
Sector (Life Science) 2 of 2
Type (Add-on Acquisition) 2 of 2
Country (China) 1 of 1
Year (2015) 2 of 2
Size (of disclosed) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2015-01-26 Sirton Pharmaceuticals

Villa Guardia, Italy

Sirton Pharmaceuticals SpA is a pharmaceutical contract manufacturing company located in Villa Guardia, near Cuomo, Italy. Sirton produces injectable pharma products, including pre-filled syringes, liquid vials, freeze-dried vials and ampoules, and pharmaceutical development services including lyophilization process development, analytical method development and validation, stability studies and manufacturing of clinical study materials.

Buy -
Mergr

Product

Company

Legal